Aurinia Pharmaceuticals Inc AUP-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 07/23/21 EDT
14.29quote price arrow down-0.26 (-1.79%)
Volume
104,131
52 week range
11.77 - 26.00

...

Loading . . .
  • Open14.61
  • Day High14.61
  • Day Low14.01
  • Prev Close14.55
  • 52 Week High26.00
  • 52 Week High Date01/25/21
  • 52 Week Low11.77
  • 52 Week Low Date05/11/21

Key Stats

  • Market Cap1,454.21M
  • Shares Out128.12M
  • 10 Day Average Volume137,365.91
  • Dividend-
  • Dividend Yield-
  • Beta0.26
  • YTD % Change-18.62

KEY STATS

  • Open14.61
  • Day High14.61
  • Day Low14.01
  • Prev Close14.55
  • 52 Week High26.00
  • 52 Week High Date01/25/21
  • 52 Week Low11.77
  • 52 Week Low Date05/11/21
  • Market Cap1,454.21M
  • Shares Out128.12M
  • 10 Day Average Volume137,365.91
  • Dividend-
  • Dividend Yield-
  • Beta0.26
  • YTD % Change-18.62

RATIOS/PROFITABILITY

  • EPS (TTM)-1.31
  • P/E (TTM)-10.88
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aurinia Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aurinia Pharmaceuticals Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases. It is developing voclosporin in multiple indications. Voclosporin is an investigational therapy. It is developing voclosporin for the treatment of lupus nephritis (LN) and other proteinuric diseases. It is also advancing voclosporin ophthalmic solution...
George Milne Jr. Ph.D.
Chairman
Peter Greenleaf
President
Joe Miller
Chief Financial Officer
Robert Huizinga
Executive Vice President
Matthew Donley
Executive Vice President
Address
1203-4464 Markham St
Victoria, BC
V8Z 7X8
Canada

Top Peers

SYMBOLLASTCHG%CHG
TRIL
Trillium Therapeutics Inc
7.20-0.18-2.44%
TH
Target Hospitality Corp
3.56-0.02-0.56%
ABUS
Arbutus Biopharma Corp
2.76-0.05-1.78%
APS
BLU
BELLUS Health Inc
2.80UNCHUNCH